Company Logo The Cancer Molecular Diagnostics market is seeing accelerated growth driven by trends like personalized medicine, pharmacogenomics, and liquid biopsy. Key opportunities lie in companion ...

(Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the formation of a newly ...

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

October 27, 2025- ( Investorideas.com Newswire), a go-to investing platform covering biotech and medtech stocks releases a ...

Breast cancer detection has evolved from microscopes to molecular precision to offer diagnostic insights: Expert: Shardul Nautiyal, Mumbai Saturday, November 1, 2025, 08:00 Hrs [I ...

The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...

The Global Sepsis Diagnostics Market size, valued at USD 1,133.2 million in 2018, grew substantially to USD 1,790.9 million in 2024. This growth is poised to accelerate, with the market projected to ...

An important scientific study published in The Lancet shows the strong public health impact of deploying molecular diagnostics closer to the people.

Roche’s diagnostics business continues to be buffeted by China headwinds, but the Swiss major believes it has enough ...

The Jongkuntang Gochon Foundation announced that it has awarded the 18th Gochon Award to Molbio Diagnostics, a molecular ...

Molbio Diagnostics receives the prestigious Kochon Prize for its innovative Truenat portable PCR system, transforming ...